4//SEC Filing
BUGG CHARLES E 4
Accession 0000882796-06-000050
CIK 0000882796other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:40 PM ET
Size
6.1 KB
Accession
0000882796-06-000050
Insider Transaction Report
Form 4
BUGG CHARLES E
DirectorChairman
Transactions
- Award
Stock Options (Right to buy)
2006-06-22$13.44/sh+49,538$665,791→ 49,538 totalExercise: $13.44From: 2007-06-22Exp: 2016-06-22→ Common Stock (49,538 underlying)
Footnotes (2)
- [F1]Of the 49,538 stock options granted to Dr. Bugg, 11,843 are incentive stock options and 37,695 are non-qualified stock options.
- [F2]Options become exercisable at the rate of 25% after 1 year and then 1/48 per month thereafter until fully vested and exercisable after 48 months.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001198765
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 4:40 PM ET
- Size
- 6.1 KB